Latest News Archive

Please select Category, Year, and then Month to display items

RSVP

Please Click Here To RSVP

RSVP

Please Click Here To RSVP

UFS hosts national Indigenous Knowledge and Bio-Trade Indaba

23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event.

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS.

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.

News Archive

It is not every day you get to build a heart

2014-09-17

According to the World Health Organisation, heart disease is the leading cause of death world wide. Heart transplantations substantially outperform any other available treatment and extend life by an average of 15 years, but the shortage of donor organs and organ rejection still remain a challenge.

Getting closer to the day where it will be possible to produce human organs by using human cells, researchers at the University of the Free State (UFS) announced that they have successfully decellularized a primate heart.

Decellularization is the process of taking an organ and stripping its cells, leaving behind a framework of binding tissue. The organ can then be repopulated (recellularized) with the patient's own cells - a process considered to move heart research closer to the day when a patient can become his own donor.

This process was discovered in 2008 by American cardiologist, Dr Doris Taylor of the University of Minnesota, who decellularized and recellularized a beating rat heart in a laboratory.

World wide researchers already used the process of decellularization on rat and pig hearts, but the research team of the UFS is the first to use this on a primate heart.

Complete media release.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept